Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | 10X Genomics Inc | 155 |
| 2 | LG Chem Ltd | 90 |
| 3 | Covestro Deutschland AG | 75 |
| 4 | Kimberly Clark Worldwide Inc | 69 |
| 5 | SmithKline Beecham Corp | 52 |
| 6 | F Hoffmann La Roche AG | 51 |
| 7 | Labrador Diagnostics LLC | 48 |
| 8 | Arkray Inc | 46 |
| 9 | Massachusetts Institute of Technology | 46 |
| 10 | Procter and Gamble Co | 41 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | A61K | Medicinal preparations | 2,929 |
| 2 | A61P | Therapeutic activity (drug indications) | 2,736 |
| 3 | G01N | Investigating / analysing materials | 1,813 |
| 4 | C12N | Microorganisms, enzymes | 1,081 |
| 5 | C07K | Peptides | 1,056 |
| 6 | C12Q | Measuring/testing involving enzymes | 873 |
| 7 | C07D | Heterocyclic compounds | 614 |
| 8 | Y02A | Climate change adaptation | 612 |
| 9 | A61L | Sterilising / disinfecting materials | 462 |
| 10 | Y10S | Cross-reference (legacy) | 252 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionMost-cited patents
Patents ranked by forward citations reveal the foundational inventions the field continues to build on.
| Title | Year | Assignee | Cited by |
|---|---|---|---|
| GRAPHIC DIAGNOSIS PROBE FOR DISEASE ACCEPTING ACCUMULATING AMYLOID BY AZURE A ANALOG COMPOUND AND COMPOSITION FOR GRAPHIC DIAGNOSIS CONTAINING THE SAME | 2000 | BF KENKYUSHO:KK | 14 |
| A kind of method of quick carry out Rui Shi Giemsa stainings | 2018 | SUZHOU FENGTAI MEDICAL SUPPLIES TRADING CO., LTD. | 8 |
| Method for purifying electronic mediator azure C | 2022 | Genclonn Biotech (Hangzhou) Co.,Ltd. | 1 |
| Method for detecting quality of Rui-Giemsa staining solution and method for improving quality of Rui-Giemsa staining solution | 2023 | HENAN CELNOVTEBIO BIOTECHNOLOGY. Inc. | 0 |
| Method for purifying electronic mediator azure C | 2022 | Genclonn Biotech (Hangzhou) Co.,Ltd. | 0 |
Where research is gaining momentum
Research themes ranked by publication activity show where scientific interest is accelerating around this compound.
| # | Research topic | Papers |
|---|---|---|
| 1 | Electrochemical sensors and biosensors | 1 |
| 2 | Food Quality and Safety Studies | 1 |
| 3 | Quinazolinone synthesis and applications | 1 |
Who's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | Guangwen Cao | Nanjing University | 4 |
| 2 | Qingcai Jiao | 4 | |
| 3 | Victor C. Yang | University of Michigan | 4 |
| 4 | Encarnación Lorenzo | Universidad Autónoma de Madrid | 3 |
| 5 | F. Pariente | Universidad Autónoma de Madrid | 3 |
| 6 | Gopinatha Suresh Kumar | Indian Institute of Chemical Biology | 3 |
| 7 | Robert A. Drongowski | University of Michigan | 3 |
| 8 | Tania García‐Mendiola | Universidad Autónoma de Madrid | 3 |
| 9 | C. Gómez-Anquela | Universidad Autónoma de Madrid | 2 |
| 10 | C.-L. C. Teng | University of Michigan | 2 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| Dendrimers as a Carrier for Pulmonary Delivery of Enoxaparin, a Low-Molecular Weight Heparin | 2007 | 155 | RNA Interference and Gene Delivery |
| Photocatalytic degradation of Azure and Sudan dyes using nano TiO2 | 2007 | 138 | TiO2 Photocatalysis and Solar Cells |
| A Metachromatic Dye-Atpase Method for The Simultaneous Identification of Skeletal Muscle Fiber Types I, IIA, IIB and IIC | 1990 | 116 | Mitochondrial Function and Pathology |
| Melanin synthesis by Sclerotinia sclerotiorum | 2009 | 93 | Phytochemicals and Antioxidant Activities |
| Potentiation of photoinactivation of Gram-positive and Gram-negative bacteria mediated by six phenothiazinium dyes by addition of azide ion | 2014 | 85 | Nanoplatforms for cancer theranostics |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the chemical composition of Azure A?
Which organizations hold the most patents related to Azure A?
How many patents and papers have been filed or published on Azure A in recent years?
What are the main research topics associated with Azure A?
What notable scientific publications reference Azure A and related compounds?